230 related articles for article (PubMed ID: 31002999)
1. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
Zhu H; Zhang Q; Chen G
Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.
Wehr A; Baeck C; Heymann F; Niemietz PM; Hammerich L; Martin C; Zimmermann HW; Pack O; Gassler N; Hittatiya K; Ludwig A; Luedde T; Trautwein C; Tacke F
J Immunol; 2013 May; 190(10):5226-36. PubMed ID: 23596313
[TBL] [Abstract][Full Text] [Related]
3. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
4. Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells.
Germanov E; Veinotte L; Cullen R; Chamberlain E; Butcher EC; Johnston B
J Immunol; 2008 Jul; 181(1):81-91. PubMed ID: 18566372
[TBL] [Abstract][Full Text] [Related]
5. Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.
Arrenberg P; Maricic I; Kumar V
Gastroenterology; 2011 Feb; 140(2):646-55. PubMed ID: 20950612
[TBL] [Abstract][Full Text] [Related]
6. Oral N-acetylcysteine decreases IFN-γ production and ameliorates ischemia-reperfusion injury in steatotic livers.
Liggett JR; Kang J; Ranjit S; Rodriguez O; Loh K; Patil D; Cui Y; Duttargi A; Nguyen S; He B; Lee Y; Oza K; Frank BS; Kwon D; Li HH; Kallakury B; Libby A; Levi M; Robson SC; Fishbein TM; Cui W; Albanese C; Khan K; Kroemer A
Front Immunol; 2022; 13():898799. PubMed ID: 36148239
[TBL] [Abstract][Full Text] [Related]
7. NKT cells are important mediators of hepatic ischemia-reperfusion injury.
Richards JA; Wigmore SJ; Anderton SM; Howie SEM
Transpl Immunol; 2017 Dec; 45():15-21. PubMed ID: 28797737
[TBL] [Abstract][Full Text] [Related]
8. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.
Kuboki S; Sakai N; Tschöp J; Edwards MJ; Lentsch AB; Caldwell CC
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1054-9. PubMed ID: 19264952
[TBL] [Abstract][Full Text] [Related]
9. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.
Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ
Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115
[TBL] [Abstract][Full Text] [Related]
10. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.
Kato H; Kuriyama N; Duarte S; Clavien PA; Busuttil RW; Coito AJ
J Hepatol; 2014 May; 60(5):1032-9. PubMed ID: 24412604
[TBL] [Abstract][Full Text] [Related]
11. Auto-aggressive CXCR6
Dudek M; Pfister D; Donakonda S; Filpe P; Schneider A; Laschinger M; Hartmann D; Hüser N; Meiser P; Bayerl F; Inverso D; Wigger J; Sebode M; Öllinger R; Rad R; Hegenbarth S; Anton M; Guillot A; Bowman A; Heide D; Müller F; Ramadori P; Leone V; Garcia-Caceres C; Gruber T; Seifert G; Kabat AM; Mallm JP; Reider S; Effenberger M; Roth S; Billeter AT; Müller-Stich B; Pearce EJ; Koch-Nolte F; Käser R; Tilg H; Thimme R; Boettler T; Tacke F; Dufour JF; Haller D; Murray PJ; Heeren R; Zehn D; Böttcher JP; Heikenwälder M; Knolle PA
Nature; 2021 Apr; 592(7854):444-449. PubMed ID: 33762736
[TBL] [Abstract][Full Text] [Related]
12. TNF
Yang F; Shang L; Wang S; Liu Y; Ren H; Zhu W; Shi X
Oxid Med Cell Longev; 2019; 2019():2301903. PubMed ID: 31214277
[TBL] [Abstract][Full Text] [Related]
13. Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers.
Kang J; Liggett JR; Patil D; Ranjit S; Loh K; Duttargi A; Cui Y; Oza K; Frank BS; Kwon D; Kallakury B; Robson SC; Fishbein TM; Cui W; Khan K; Kroemer A
Front Immunol; 2022; 13():899525. PubMed ID: 35833123
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
Wehr A; Baeck C; Ulmer F; Gassler N; Hittatiya K; Luedde T; Neumann UP; Trautwein C; Tacke F
PLoS One; 2014; 9(11):e112327. PubMed ID: 25372401
[TBL] [Abstract][Full Text] [Related]
15. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.
Lappas CM; Day YJ; Marshall MA; Engelhard VH; Linden J
J Exp Med; 2006 Nov; 203(12):2639-48. PubMed ID: 17088433
[TBL] [Abstract][Full Text] [Related]
16. Viral interleukin-10 gene transfer prevents liver ischemia-reperfusion injury: Toll-like receptor-4 and heme oxygenase-1 signaling in innate and adaptive immunity.
Ke B; Shen XD; Tsuchihashi S; Gao F; Araujo JA; Busuttil RW; Ritter T; Kupiec-Weglinski JW
Hum Gene Ther; 2007 Apr; 18(4):355-66. PubMed ID: 17439357
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
18. Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-I dysfunction.
Chu MJ; Premkumar R; Hickey AJ; Jiang Y; Delahunt B; Phillips AR; Bartlett AS
World J Gastroenterol; 2016 May; 22(19):4673-84. PubMed ID: 27217699
[TBL] [Abstract][Full Text] [Related]
19. The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.
Liss KHH; McCommis KS; Chambers KT; Pietka TA; Schweitzer GG; Park SL; Nalbantoglu I; Weinheimer CJ; Hall AM; Finck BN
Liver Transpl; 2018 Jul; 24(7):908-921. PubMed ID: 29729104
[TBL] [Abstract][Full Text] [Related]
20. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury.
Li L; Huang L; Sung SS; Lobo PI; Brown MG; Gregg RK; Engelhard VH; Okusa MD
J Immunol; 2007 May; 178(9):5899-911. PubMed ID: 17442974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
